Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now full pipeline small index

Sentinel Lymph Node: full-pipeline trial registry

5 of 6 indexed Sentinel Lymph Node trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 5 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Sentinel Lymph Node: 6 US clinical trials tracked, 5 recruiting.

Sentinel Lymph Node is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University Medical Center Groningen, running 1 of these trials.

Enrollment posture brief

Registry condition sentinel-lymph-node

OPEN 5 | RECR 83% | LATE 2 | EARLY 2 | RANK #2866 | SPON 1

Nearest open-share peer: Alcoholic Hepatitis (83% recruiting · 6 trials)

Sentinel Lymph Node (this)83%Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%
Open-enrollment share among volume-matched conditions near Sentinel Lymph Node

Sentinel Lymph Node lists 5 open slots (83% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Sentinel Lymph Node on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Sentinel Lymph Node is recruiting above its size-band peers.

    5 of 6 indexed trials (83.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Sentinel Lymph Node research.

    University Medical Center Groningen accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Sentinel Lymph Node enrolment sits around 157 participants.

    Median target enrolment is 157 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.

  4. Sentinel Lymph Node research is mostly interventional.

    6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21Phase 32

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 2

Named interventions

Most-linked intervention names on Sentinel Lymph Node records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Radiotherapy combined with cisplatin Radiation
1 trials
Lymphoscintigraphy Procedure
1 trials
TH BSO without retroperitoneal node dissection Note: If participants (≤45yo), Grade 1 endometrial adenocarcinoma with myometrial invasion <50%, wish to retain their ovaries a BSO may be omitted Procedure
1 trials
TH BSO with SNB Note: If participants (≤45yo), Grade 1 endometrial adenocarcinoma with myometrial invasion <50%, wish to retain their ovaries a BSO may be omitted Procedure
1 trials
Late SLND Diagnostic test
1 trials
Delayed SLND Diagnostic test
1 trials
Video Other
1 trials
Near Infrared Imaging Device
1 trials

US sites by state

Facility locations filed on Sentinel Lymph Node trials. A trial with sites in several states counts in each.

Massachusetts 3 trials
Texas 2 trials
North Carolina 2 trials
Rhode Island 1 trials
Oklahoma 1 trials
Ohio 1 trials
New York 1 trials
Nevada 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Sentinel Lymph Node page

6 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sentinel Lymph Node condition card totals 6 registered trials; most-linked intervention Radiotherapy combined with cisplatin; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.